Cosopt Pf Solution/ Drops
NDC Package 82584-604-30
Package Information
Cosopt Pf (dorzolamide hydrochloride and timolol maleate) solution/ dropses is cOSOPT® PF is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time).The IOP-lowering of COSOPT® administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see Clinical Studies (14.1)]. This formulation utilizes a solution/ drops delivery system. Marketed by Thea Pharma Inc., this product is identified by NDC 82584-604 and is authorized under FDA application NDA202667.
Identification & Billing
- RxCUI: 1922783 - dorzolamide 2 % / timolol 0.5 % PF Ophthalmic Solution
- RxCUI: 1922783 - Preservative-Free dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution
- RxCUI: 1922784 - COSOPT PF 2 % / 0.5 % Ophthalmic Solution
- RxCUI: 1922784 - Preservative-Free dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Cosopt]
- RxCUI: 1922784 - Cosopt PF (dorzolamide 2 % / timolol 0.5 % ) Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82584 - Thea Pharma Inc.
- 82584-604 - Cosopt Pf
- 82584-604-30 - 4 POUCH in 1 CARTON / 15 VIAL, SINGLE-DOSE in 1 POUCH (82584-604-01) / .2 mL in 1 VIAL, SINGLE-DOSE
- 82584-604 - Cosopt Pf
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82584-604-30 identifies a specific commercial package of 4 pouch in 1 carton / 15 vial, single-dose in 1 pouch (82584-604-01) / .2 ml in 1 vial, single-dose of Cosopt Pf, a human prescription drug labeled by Thea Pharma Inc.. This solution/ drops is formulated for ophthalmic use and contains dorzolamide hydrochloride; timolol maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Thea Pharma Inc. on December 10, 2022. The current certification is valid through December 31, 2027.
How is this Thea Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82584060430. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.